ELOXX PHARMACEUTICALS, INC. Dividends Declared
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Dividends Declared of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-06.
Discontinued › Shareholders' Equity › Dividends
us-gaap:Dividends · last filed 2020-03-06
- ELOXX PHARMACEUTICALS, INC. dividends for the quarter ending 2014-09-30 was -$14.50K, a 261.11% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. dividends for the quarter ending 2014-06-30 was -$14.50K.
- ELOXX PHARMACEUTICALS, INC. dividends for the quarter ending 2014-03-31 was $14.50K, a 41.71% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. dividends for the quarter ending 2013-12-31 was $5.50K.
- ELOXX PHARMACEUTICALS, INC. dividends for fiscal 2019 was $0.00.
- ELOXX PHARMACEUTICALS, INC. dividends for fiscal 2018 was $0.00.
- ELOXX PHARMACEUTICALS, INC. dividends for fiscal 2017 was $0.00.
- ELOXX PHARMACEUTICALS, INC. dividends for fiscal 2014 was $14.50K, a 27.50% decline from fiscal 2013.
| Period end | Dividends 3 month | Dividends 6 month | Dividends 9 month | Dividends 12 month | Dividends 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-06 | ||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-06 | ||||
| 2017-12-31 | $0.00 10-K · filed 2018-03-16 | ||||
| 2014-09-30 | -$14.50K 10-Q · filed 2014-11-14 | -$29.00K derived: sum of 2 quarters · filed 2016-10-13 | -$14.50K derived: sum of 3 quarters · filed 2016-10-13 | -$9.00K derived: sum of 4 quarters · filed 2016-10-13 | |
| 2014-06-30 | -$14.50K derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | $0.00 derived: sum of 2 quarters · filed 2016-10-13 | $5.50K derived: sum of 3 quarters · filed 2016-10-13 | $14.50K 10-K · filed 2016-10-13 | -$14.50K 10-K · filed 2014-09-29 |
| 2014-03-31 | $14.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | $20.00K derived: sum of 2 quarters · filed 2014-05-09 | $29.00K 10-Q · filed 2014-05-09 | -$752.00 derived: sum of 4 quarters · filed 2015-10-09 | |
| 2013-12-31 | $5.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | $14.50K 10-Q · filed 2014-02-14 | -$15.25K derived: sum of 3 quarters · filed 2015-10-09 | $9.62K derived: sum of 4 quarters · filed 2015-10-09 | |
| 2013-09-30 | $9.00K 10-Q · filed 2013-11-14 | -$20.75K derived: sum of 2 quarters · filed 2015-10-09 | $4.12K derived: sum of 3 quarters · filed 2015-10-09 | -$20.75K derived: sum of 4 quarters · filed 2015-10-09 | |
| 2013-06-30 | -$29.75K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-09 | -$4.88K derived: sum of 2 quarters · filed 2015-10-09 | -$29.75K derived: sum of 3 quarters · filed 2015-10-09 | $20.00K 10-K · filed 2015-10-09 | -$20.00K 10-K · filed 2013-09-11 |
| 2013-03-31 | $24.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | $0.00 derived: sum of 2 quarters · filed 2013-05-15 | $49.75K 10-Q · filed 2013-05-15 | -$306.97K derived: sum of 4 quarters · filed 2014-09-29 | |
| 2012-12-31 | -$24.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | $24.88K 10-Q · filed 2013-02-14 | -$331.85K derived: sum of 3 quarters · filed 2014-09-29 | -$210.72K derived: sum of 4 quarters · filed 2014-09-29 | |
| 2012-09-30 | $49.75K 10-Q · filed 2012-11-14 | -$306.97K derived: sum of 2 quarters · filed 2014-09-29 | -$185.85K derived: sum of 3 quarters · filed 2014-09-29 | -$184.72K derived: sum of 4 quarters · filed 2014-09-29 | |
| 2012-06-30 | -$356.72K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | -$235.60K derived: sum of 2 quarters · filed 2014-09-29 | -$234.47K derived: sum of 3 quarters · filed 2014-09-29 | -$114.47K 10-K · filed 2014-09-29 | $114.47K 10-K/A · filed 2012-10-26 |
| 2012-03-31 | $121.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14 | $122.25K derived: sum of 2 quarters · filed 2012-05-14 | $242.25K 10-Q · filed 2012-05-14 | ||
| 2011-12-31 | $1.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | $121.13K 10-Q · filed 2012-02-14 | |||
| 2011-09-30 | $120.00K 10-Q · filed 2011-11-14 | ||||
| 2011-06-30 | -$122.25K 10-K · filed 2013-09-11 | $122.25K 10-K/A · filed 2012-10-26 | |||
| 2010-06-30 | -$230.88K 10-K · filed 2013-09-11 | $230.88K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |